Update
$Cognition Therapeutics (CGTX.US)$ Reuters· just
Cognition Therapeutics Publishes Eeg Findings From Phase 2 Sequel Study of Ct1812 in Mild-to-Moderate Alzheimer’s Disease
Cognition Therapeutics Publishes Eeg Findings From Phase 2 Sequel Study of Ct1812 in Mild-to-Moderate Alzheimer’s Disease
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
